A detailed history of Susquehanna International Group, LLP transactions in Axonics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 13,288 shares of AXNX stock, worth $943,182. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,288
Previous 10,239 29.78%
Holding current value
$943,182
Previous $688,000 34.45%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$67.3 - $69.67 $205,197 - $212,423
3,049 Added 29.78%
13,288 $925,000
Q2 2024

Aug 15, 2024

BUY
$66.47 - $69.65 $468,148 - $490,544
7,043 Added 220.37%
10,239 $688,000
Q1 2024

May 07, 2024

SELL
$56.67 - $69.36 $774,452 - $947,873
-13,666 Reduced 81.05%
3,196 $220,000
Q4 2023

Feb 14, 2024

BUY
$49.38 - $63.75 $41,479 - $53,550
840 Added 5.24%
16,862 $1.05 Million
Q3 2023

Nov 14, 2023

SELL
$48.64 - $62.51 $393,692 - $505,955
-8,094 Reduced 33.56%
16,022 $899,000
Q2 2023

Aug 11, 2023

BUY
$47.99 - $60.21 $104,330 - $130,896
2,174 Added 9.91%
24,116 $1.22 Million
Q1 2023

May 16, 2023

BUY
$52.6 - $67.34 $641,351 - $821,076
12,193 Added 125.07%
21,942 $1.2 Million
Q4 2022

Feb 14, 2023

SELL
$59.56 - $76.6 $1.21 Million - $1.56 Million
-20,342 Reduced 67.6%
9,749 $609,000
Q3 2022

Nov 14, 2022

BUY
$57.96 - $78.12 $396,968 - $535,043
6,849 Added 29.47%
30,091 $2.12 Million
Q2 2022

Aug 15, 2022

SELL
$39.5 - $64.42 $506,982 - $826,830
-12,835 Reduced 35.58%
23,242 $1.32 Million
Q1 2022

May 16, 2022

BUY
$43.74 - $62.76 $647,833 - $929,538
14,811 Added 69.65%
36,077 $2.26 Million
Q4 2021

Feb 14, 2022

BUY
$50.01 - $73.35 $227,595 - $333,815
4,551 Added 27.23%
21,266 $1.19 Million
Q3 2021

Nov 15, 2021

SELL
$59.21 - $78.66 $1.62 Million - $2.16 Million
-27,444 Reduced 62.15%
16,715 $1.09 Million
Q2 2021

Aug 11, 2021

BUY
$51.39 - $66.9 $910,014 - $1.18 Million
17,708 Added 66.95%
44,159 $2.8 Million
Q4 2020

Feb 16, 2021

SELL
$42.19 - $51.5 $1.92 Million - $2.34 Million
-45,507 Reduced 63.24%
26,451 $1.32 Million
Q3 2020

Nov 16, 2020

BUY
$35.33 - $51.04 $2.32 Million - $3.36 Million
65,737 Added 1056.7%
71,958 $3.67 Million
Q2 2020

Aug 14, 2020

SELL
$22.91 - $39.83 $182,294 - $316,927
-7,957 Reduced 56.12%
6,221 $218,000
Q1 2020

May 15, 2020

SELL
$16.44 - $37.73 $115,819 - $265,807
-7,045 Reduced 33.2%
14,178 $360,000
Q4 2019

Feb 14, 2020

BUY
$19.57 - $28.96 $200,220 - $296,289
10,231 Added 93.08%
21,223 $588,000
Q3 2019

Nov 14, 2019

BUY
$26.92 - $42.41 $132,069 - $208,063
4,906 Added 80.61%
10,992 $296,000
Q2 2019

Aug 16, 2019

BUY
$18.54 - $40.97 $112,834 - $249,343
6,086 New
6,086 $249,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.